Efficacy of immune checkpoint inhibitors in patients with non-small cell lung cancer harboring ERBB2 exon 20 insertions and non-ERBB2 exon 20 insertions

被引：0
|
作者：
Tu, Hai-Yan
Kai Yin
Ke, E-E
Wu, Si-Pei
Zhao, Xiaotian
Li, Yang-Si
Zheng, Mei-Mei
Liu, Si-Yang Maggie
Sun, Yue-Li
Lin, Jia-Xin
Bai, Xiao-Yan
Zhang, Yi-Chen
Qing Zhou
Yang, Jin-Ji
Zhong, Wenzhao
Wang, Bin-Chao
Zhu, Dongqin
Yang, Lingling
Ou, Qiuxiang
Wu, Yi-Long
机构：
[1] South China Univ Technol, Guangdong Acad Med Sci, Guangdong Lung Canc Inst, Guangdong Prov Peoples Hosp,Sch Med, Guangzhou, Peoples R China
[2] Southern Med Univ, Guangdong Lung Canc Inst, Guangdong Prov Peoples Hosp, Guangdong Acad Med Sci,Sch Clinical Med 2, Guangzhou, Peoples R China
[3] Guangdong Prov Peoples Hosp, Guangdong Acad Med Sci, Guangdong Lung Canc Inst, Guangzhou, Peoples R China
[4] Guangdong Prov Peoples Hosp, Guangdong Acad Med Sci, Guangdong Lung Canc Inst, Guangdong Prov Key Lab Translat Med Lung Canc, Guangzhou, Peoples R China
[5] Nanjing Geneseeq Technol Inc, Geneseeq Res Inst, Nanjing, Peoples R China
[6] Jinan Univ Chinese, Dept Hematol, Sch Med, Affiliated Hosp 1,Inst Hematol,Key Lab Regenerati, Jinan, Peoples R China
[7] Chinese Thorac Oncol Grp CTONG, Guangzhou, Peoples R China
[8] Guangdong Prov Peoples Hosp, Guangdong Lung Canc Inst, Guangzhou, Peoples R China
[9] Guangdong Acad Med Sci, Guangzhou, Peoples R China
[10] Guangdong Prov Peoples Hosp, Dept Guangdong Lung Canc Inst, Guangzhou, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2591
引用
收藏
页数：1
相关论文
共 50 条
  • [1] ERBB2 exon 20 insertions are rare in Brazilian non-small cell lung cancer
    Cavagna, Rodrigo de Oliveira
    Zaniolo, Beatriz Garbe
    de Paula, Flavia Escremim
    Berardinelli, Gustavo Noriz
    Santana, Iara
    Albino da Silva, Eduardo Caetano
    Dias, Josiane Mourao
    Jacinto, Alexandre Arthur
    Noleto da Nobrega Oliveira, Rachid Eduardo
    de Marchi, Pedro
    Leal, Leticia Ferro
    Reis, Rui Manuel
    THORACIC CANCER, 2022, 13 (23) : 3402 - 3407
  • [2] Poor Efficacy of Immune Checkpoint Inhibitors Plus Chemotherapy in Lung Cancer Patients with EGFR/ERBB2 Exon 20 Insertion
    Zheng, Yue
    Fu, Yang
    Chen, Yueyun
    Li, Qing
    Liu, Ting
    Ding, Zhenyu
    CURRENT ONCOLOGY, 2023, 30 (11) : 9929 - 9939
  • [3] Lung adenocarcinoma with ERBB2 exon 20 insertions: Comutations and immunogenomic features related to chemoimmunotherapy
    Tian, Panwen
    Zeng, Hao
    Ji, Liyan
    Ding, Zhenyu
    Li Ren
    Gao, Wen
    Fan, Zaiwen
    Li, Lin
    Le, Xiuning
    Li, Pansong
    Zhang, Min
    Xia, Xuefeng
    Zhang, Jianjun
    Li, Yalun
    Li, Weimin
    LUNG CANCER, 2021, 160 : 50 - 58
  • [4] Clinical characterization of ERBB2 exon 20 insertions and heterogeneity of outcomes responding to afatinib in Chinese lung cancer patients
    Liu, Zhefeng
    Wu, Lin
    Cao, Jun
    Yang, Zhe
    Zhou, Chengzhi
    Cao, Liming
    Wu, Hao
    Shen, Haibo
    Jin, Meiling
    Zhang, Yong
    Mao, Xinru
    Xiang, Jianxing
    Ma, Ke
    Li, Bing
    Zhang, Tengfei
    Hu, Yu
    ONCOTARGETS AND THERAPY, 2018, 11 : 7323 - 7331
  • [5] Clinical Characterization Of ERBB2 Exon 20 Insertions and Heterogeneity of Outcomes to Afatinib in Chinese Lung Cancers
    Liu, Z.
    Hu, Y.
    Wu, L.
    Cao, J.
    Yang, Z.
    Zhou, C.
    Cao, L.
    Wu, H.
    Shen, H.
    Jin, M.
    Zhang, Y.
    Xiang, J.
    Ma, K.
    Li, B.
    Zhang, T.
    Mao, X.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (12) : S1046 - S1047
  • [6] Clinical Characterization of ERBB2 Exon 20 Insertions and Heterogeneity of Outcomes to Afatinib in Chinese Lung Cancers
    Hu, Y.
    Liu, Z.
    Wu, L.
    Cao, J.
    Yang, Z.
    Zhou, C.
    Cao, L.
    Wu, H.
    Shen, H.
    Jin, M.
    Zhang, Y.
    Mao, X.
    Xiang, J.
    Ma, K.
    Li, B.
    Zhang, T.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S484 - S485
  • [7] Clinical characteristics of advanced non-small cell lung cancer patients with EGFR exon 20 insertions
    Morita, Chie
    Yoshida, Tatsuya
    Shirasawa, Masayuki
    Masuda, Ken
    Matsumoto, Yuji
    Shinno, Yuki
    Yagishita, Shigehiro
    Okuma, Yusuke
    Goto, Yasushi
    Horinouchi, Hidehito
    Yamamoto, Noboru
    Motoi, Noriko
    Yatabe, Yasushi
    Ohe, Yuichiro
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [8] Clinical characteristics of advanced non-small cell lung cancer patients with EGFR exon 20 insertions
    Chie Morita
    Tatsuya Yoshida
    Masayuki Shirasawa
    Ken Masuda
    Yuji Matsumoto
    Yuki Shinno
    Shigehiro Yagishita
    Yusuke Okuma
    Yasushi Goto
    Hidehito Horinouchi
    Noboru Yamamoto
    Noriko Motoi
    Yasushi Yatabe
    Yuichiro Ohe
    Scientific Reports, 11
  • [9] EGFR and ERBB2 Exon 20 Insertion in Advanced Non-Small Cell Lung Cancer: Genomic Profiling and Clinicopathologic Features
    Dundar, Bilge
    Sompallae, Ramakrishna
    Guseva, Natalya
    Bossler, Aaron
    Ma, Deqin
    LABORATORY INVESTIGATION, 2022, 102 (SUPPL 1) : 1299 - 1301
  • [10] EGFR and ERBB2 Exon 20 Insertion in Advanced Non-Small Cell Lung Cancer: Genomic Profiling and Clinicopathologic Features
    Dundar, Bilge
    Sompallae, Ramakrishna
    Guseva, Natalya
    Bossler, Aaron
    Ma, Deqin
    MODERN PATHOLOGY, 2022, 35 (SUPPL 2) : 1299 - 1301
12345